{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T13:22:52Z","timestamp":1776086572654,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,20]]},"DOI":"10.7759\/cureus.80902","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T21:31:56Z","timestamp":1742506316000},"source":"Crossref","is-referenced-by-count":2,"title":["Drug-Drug Interactions Leading to Tacrolimus Toxicity in a Renal Transplant Patient With COVID-19: The Role of Paxlovid and the Mitigating Use of Phenytoin"],"prefix":"10.7759","author":[{"given":"Ricardo A","family":"Pagan Santini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinay","family":"Nair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilan","family":"Berlinrut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gayatri","family":"Nair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhu","family":"Bhaskaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/375263","article-title":"Treatment of acute tacrolimus toxicity with phenytoin in solid organ transplant recipients","volume":"375263","author":"Jantz","year":"2013","unstructured":"Jantz, A. S., Patel, S. J., Suki, W. N.. Treatment of acute tacrolimus toxicity with phenytoin in solid organ transplant recipients. Case reports in transplantation. 2013, 375263:1-6. 10.1155\/2013\/375263","journal-title":"Case reports in transplantation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.23876\/j.krcp.22.218","article-title":"Treatment of acute tacrolimus toxicity with phenytoin after Paxlovid (nirmatrelvir\/ritonavir) administration in a kidney transplant recipient","volume":"41","author":"Kwon EJ","year":"2022","unstructured":"Kwon EJ, Yun GA, Park S, et al.. Treatment of acute tacrolimus toxicity with phenytoin after Paxlovid (nirmatrelvir\/ritonavir) administration in a kidney transplant recipient. Kidney Res Clin Pract. 2022, 41:768-70. 10.23876\/j.krcp.22.218","journal-title":"Kidney Res Clin Pract"},{"key":"ref3","article-title":"Acute tacrolimus poisoning treated with phenytoin","volume":"27","author":"Khorsan R","year":"2023","unstructured":"Khorsan R, Mrinalini S\r\n\r\n\r\n. Acute tacrolimus poisoning treated with phenytoin. Proc UCLA Health. 2023, 27:A230515RK.","journal-title":"Proc UCLA Health"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/2324709618765862","article-title":"Phenytoin and rifampin do not decrease levels in acute tacrolimus toxicity","volume":"6","author":"Lawson BO","year":"2018","unstructured":"Lawson BO, Seth H, Quan D. Phenytoin and rifampin do not decrease levels in acute tacrolimus toxicity. J Investig Med High Impact Case Rep. 2018, 6:2324709618765862. 10.1177\/2324709618765862","journal-title":"J Investig Med High Impact Case Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1053\/jlts.2002.34880","article-title":"The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients","volume":"8","author":"Jain AK","year":"2002","unstructured":"Jain AK, Venkataramanan R, Shapiro R, et al.. The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients. Liver Transpl. 2002, 8:841-5. 10.1053\/jlts.2002.34880","journal-title":"Liver Transpl"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s0163-7258(01)00165-6","article-title":"Alteration of drug biotransformation and elimination during infection and inflammation","volume":"92","author":"Renton KW","year":"2001","unstructured":"Renton KW. Alteration of drug biotransformation and elimination during infection and inflammation. Pharmacol Ther. 2001, 92:147-63. 10.1016\/s0163-7258(01)00165-6","journal-title":"Pharmacol Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/s0041-1345(00)00996-9","article-title":"Use of phenobarbital in the management of acute tacrolimus toxicity: a case report","volume":"32","author":"McLaughlin GE","year":"2000","unstructured":"McLaughlin GE, Rossique-Gonzalez M, Gelman B, Kato T. Use of phenobarbital in the management of acute tacrolimus toxicity: a case report. Transplant Proc. 2000, 32:665-8. 10.1016\/s0041-1345(00)00996-9","journal-title":"Transplant Proc"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1128\/aac.02404-21","article-title":"New perspectives on antimicrobial agents: molnupiravir and nirmatrelvir\/ritonavir for treatment of COVID-19","volume":"66","author":"Atmar RL","year":"2022","unstructured":"Atmar RL, Finch N. New perspectives on antimicrobial agents: molnupiravir and nirmatrelvir\/ritonavir for treatment of COVID-19. Antimicrob Agents Chemother. 2022, 66:e0240421. 10.1128\/aac.02404-21","journal-title":"Antimicrob Agents Chemother"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7341493","article-title":"Paxlovid: Mechanism of action, synthesis, and in silico study","volume":"2022","author":"Marzi M","year":"2022","unstructured":"Marzi M, Vakil MK, Bahmanyar M, Zarenezhad E. Paxlovid: Mechanism of action, synthesis, and in silico study. Biomed Res Int. 2022, 2022:7341493. 10.1155\/2022\/7341493","journal-title":"Biomed Res Int"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2023.105555","article-title":"Nirmatrelvir exerts distinct antiviral potency against different human coronaviruses","volume":"211","author":"Li J","year":"2023","unstructured":"Li J, Wang Y, Solanki K, et al.. Nirmatrelvir exerts distinct antiviral potency against different human coronaviruses. Antiviral Res. 2023, 211:105555. 10.1016\/j.antiviral.2023.105555","journal-title":"Antiviral Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajps.2016.04.003","article-title":"Effects of duration of phenytoin administration on mRNA expression of cytochrome P450 and P-glycoprotein in the liver and small intestine of rats","volume":"11","author":"Kawase A","year":"2016","unstructured":"Kawase A, Tanaka H, Otori T. Effects of duration of phenytoin administration on mRNA expression of cytochrome P450 and P-glycoprotein in the liver and small intestine of rats.     Asian J Pharm Sci. 2016, 11: 662-7. 10.1016\/j.ajps.2016.04.003","journal-title":"Asian J Pharm Sci"},{"key":"ref12","unstructured":"Drug Metabolism - The Importance of Cytochrome P450 3A4. (2014). Accessed. 2025: https:\/\/www.medsafe.govt.nz\/profs\/puarticles\/march2014drugmetabolismcytochromep4503a4.htm."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1993.tb17137.x","article-title":"The mechanism of action of FK-506 and cyclosporin A","volume":"696","author":"Wiederrecht G","year":"1993","unstructured":"Wiederrecht G, Lam E, Hung S, Martin M, Sigal N. The mechanism of action of FK-506 and cyclosporin A. Ann N Y Acad Sci. 1993, 696:9-19. 10.1111\/j.1749-6632.1993.tb17137.x","journal-title":"Ann N Y Acad Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.6004\/jadpro.2013.4.4.7","article-title":"Basic review of the cytochrome p450 system","volume":"4","author":"McDonnell AM","year":"2013","unstructured":"McDonnell AM, Dang CH. Basic review of the cytochrome p450 system. J Adv Pract Oncol. 2013, 4:263-8. 10.6004\/jadpro.2013.4.4.7","journal-title":"J Adv Pract Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra033540","article-title":"Immunosuppressive drugs for kidney transplantation","volume":"351","author":"Halloran PF","year":"2004","unstructured":"Halloran PF. Immunosuppressive drugs for kidney transplantation. N Engl J Med. 2004, 351:2715-29. 10.1056\/NEJMra033540","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000104908.75206.26","article-title":"Comparative CYP3A4 inhibitory effects of venlafaxine, fluoxetine, sertraline, and nefazodone in healthy volunteers","volume":"24","author":"DeVane CL","year":"2004","unstructured":"DeVane CL, Donovan JL, Liston HL, Markowitz JS, Cheng KT, Risch SC, Willard L. Comparative CYP3A4 inhibitory effects of venlafaxine, fluoxetine, sertraline, and nefazodone in healthy volunteers. J Clin Psychopharmacol. 2004, 24:4-10. 10.1097\/01.jcp.0000104908.75206.26","journal-title":"J Clin Psychopharmacol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2022.01.001","article-title":"Special considerations for Paxlovid treatment among transplant recipients with SARS-CoV-2 infection","volume":"79","author":"Fishbane S","year":"2022","unstructured":"Fishbane S, Hirsch JS, Nair V. Special considerations for Paxlovid treatment among transplant recipients with SARS-CoV-2 infection. Am J Kidney Dis. 2022, 79:480-2. 10.1053\/j.ajkd.2022.01.001","journal-title":"Am J Kidney Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/347801-drug-drug-interactions-leading-to-tacrolimus-toxicity-in-a-renal-transplant-patient-with-covid-19-the-role-of-paxlovid-and-the-mitigating-use-of-phenytoin","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T21:32:07Z","timestamp":1742506327000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/347801-drug-drug-interactions-leading-to-tacrolimus-toxicity-in-a-renal-transplant-patient-with-covid-19-the-role-of-paxlovid-and-the-mitigating-use-of-phenytoin"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,20]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.80902","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,20]]}}}